FANCD2 - FA complementation group D2 Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102142866
FANCD2 Products (19)
| mRNA | Protein | Name |
|---|---|---|
| XM_045385760.1 | XP_045241695.1 | Fanconi anemia group D2 protein isoform X5 |
| XM_045385764.1 | XP_045241699.1 | Fanconi anemia group D2 protein isoform X8 |
| XM_045385758.1 | XP_045241693.1 | Fanconi anemia group D2 protein isoform X3 |
| XM_045385761.1 | XP_045241696.1 | Fanconi anemia group D2 protein isoform X5 |
| XM_045385773.1 | XP_045241708.1 | Fanconi anemia group D2 protein isoform X13 |
| XM_045385768.1 | XP_045241703.1 | Fanconi anemia group D2 protein isoform X12 |
| XM_045385757.1 | XP_045241692.1 | Fanconi anemia group D2 protein isoform X2 |
| XM_045385767.1 | XP_045241702.1 | Fanconi anemia group D2 protein isoform X11 |
| XM_045385765.1 | XP_045241700.1 | Fanconi anemia group D2 protein isoform X9 |
| XM_045385763.1 | XP_045241698.1 | Fanconi anemia group D2 protein isoform X7 |
| XM_045385766.1 | XP_045241701.1 | Fanconi anemia group D2 protein isoform X10 |
| XM_045385762.1 | XP_045241697.1 | Fanconi anemia group D2 protein isoform X6 |
| XM_045385759.1 | XP_045241694.1 | Fanconi anemia group D2 protein isoform X4 |
| XM_045385755.1 | XP_045241690.1 | Fanconi anemia group D2 protein isoform X1 |
| XM_045385770.1 | XP_045241705.1 | Fanconi anemia group D2 protein isoform X12 |
| XM_045385769.1 | XP_045241704.1 | Fanconi anemia group D2 protein isoform X12 |
| XM_045385756.1 | XP_045241691.1 | Fanconi anemia group D2 protein isoform X1 |
| XM_045385772.1 | XP_045241707.1 | Fanconi anemia group D2 protein isoform X12 |
| XM_045385771.1 | XP_045241706.1 | Fanconi anemia group D2 protein isoform X12 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
Fanconi anemia group D2 protein |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-160700 | TNG348 | Inhibitor | 99.74% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(10)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14520 | Tetrahydrofolic acid | 96.77% | Unkown | |
| HY-123834 | FEN1-IN-1 | 99.85% | Unkown | |
| HY-126539 | UBE2T/FANCL-IN-1 | 99.36% | Unkown | |
| HY-153365 | I-138 | Inhibitor | 99.75% | Unkown |
| HY-14520A | (6S)-Tetrahydrofolic acid | / | Unkown | |
| HY-RS04735 | FANCD2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-139621 | Colibactin 742 | / | Unkown | |
| HY-14520B | Tetrahydrofolic acid trihydrochloride | / | Unkown | |
| HY-RS17257 | Fancd2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23711 | Fancd2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service